Blood Cancer Journal
-
Publication Venue For
- Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms.. 12:25. 2022
- A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.. 11:149. 2021
- Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry.. 11:134. 2021
- Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.. 11:92. 2021
- A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.. 11:89. 2021
- Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change.. 11:29. 2021
- Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features. 10. 2020
- CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.. 10:69. 2020
- Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.. 10:49. 2020
- Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.. 9:59. 2019
- Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma.. 8:71. 2018
- Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.. 7:e520. 2017
- Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL.. 6:e440. 2016
- The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma.. 6:e395. 2016
- Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma.. 5:e359. 2015
- Fanconi anemia gene variants in therapy-related myeloid neoplasms.. 5:e323. 2015